Arcutis Biotherapeutics, Inc. ARQT Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s investment purchases?
- Arcutis Biotherapeutics, Inc. (ARQT) reported investment purchases of $62.15M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s investment purchases changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s investment purchases increased by 10.8% year-over-year, from $56.11M to $62.15M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s investment purchases?
- Over 4 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s investment purchases has grown at a -4.1% compound annual growth rate (CAGR), from $292.51M to $246.99M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.